Philipp Schredl

Philipp Schredl is a Specialist at the University Clinic for Surgery, Salzburger Landeskliniken (SALK), Austria. He is actively engaged in colorectal and oncological surgery, with a strong research focus on rectal cancer, total mesorectal excision, neoadjuvant therapy, and surgical innovation. He collaborates extensively with multidisciplinary teams in radiation oncology and surgical oncology.

• University: Salzburger Landeskliniken
• School: University Clinic for Surgery
• Position: Specialist
• Email: p.schredl@salk.at

Dr. Schredl's research interests center on improving surgical outcomes in colorectal cancer. Key areas include rectal cancer management, preservation of the ileocecal valve, intraoperative radiation techniques, and peritoneal surface malignancies. His work integrates clinical practice with technological innovation, as seen in the development of SAPESUCA, a web-based tool for peritoneal surface area quantification. He also investigates the impact of neoadjuvant therapy on surgical precision and long-term functional outcomes.

The most recent publications reflect a strong trend in oncological surgery, technical innovation, and multidisciplinary collaboration. Articles span topics from surgical complications (e.g., clip migration) to nationwide surveys on surgical practices and the development of clinical tools. The research emphasizes evidence-based practice, patient-centered outcomes, and the integration of radiotherapy in surgical oncology.

Dr. Schredl has no listed scientific awards in the provided text.

He is actively involved in academic and clinical leadership, having co-organized major surgical events such as the STAR Course - Peritonektomie & HIPEC, the Chirurgische Festspiele Salzburg, and the 1. Expertenmeeting Salzburg. These roles indicate his engagement in surgical education and interdisciplinary oncology. There is no mention of specific grants, but his participation in multicenter studies (e.g., ACO-ASSO CRC study group) suggests involvement in collaborative research funding.

He is a key member of surgical and oncological teams focused on peritoneal surface malignancies and complex colorectal procedures, contributing to both clinical care and academic advancement in surgical oncology.